Nemea Therapeutics, Inc.
PrivateLast Round
Seed
Apr 1, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Nemea Therapeutics, Inc. is a biotechnology company developing oral small molecule inhibitors targeting mitochondrial RNA polymerase for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nemea Therapeutics, Inc. Comparables
Compare Nemea Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Imel Biotherapeutics | 77% | |
| Talus Bio | 77% | |
| KyDo Therapeutics | 75% | |
Nemea Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 1, 2026 | ||||
| Pre Seed | Nov 1, 2025 |
Nemea Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KHAN Technology Transfer Fund II | Pre Seed |
| MATWIN | Accelerator |
| BCM Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
$25M raised in Seed round.
- Nov 1, 2025
$2M raised from BCM Ventures and KHAN Technology Transfer Fund II.
Nemea Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nemea Therapeutics, Inc.'s valuation, stock price, and market status.